Ertapenem en es it fr

Ertapenem Brand names, Ertapenem Analogs

Ertapenem Brand Names Mixture

  • No information avaliable

Ertapenem Chemical_Formula


Ertapenem RX_link

Ertapenem fda sheet

Ertapenem FDA

Ertapenem msds (material safety sheet)

Ertapenem Synthesis Reference

No information avaliable

Ertapenem Molecular Weight

475.516 g/mol

Ertapenem Melting Point

No information avaliable

Ertapenem H2O Solubility

Soluble as sodium salt

Ertapenem State


Ertapenem LogP


Ertapenem Dosage Forms

Powder for solution

Ertapenem Indication

For the treatment the following moderate to severe infections caused by susceptible isolates of the designated microorganisms: (1) complicated intra-abdominal infections due to Escherichia coli, Clostridium clostridioforme, Eubacterium lentum, Peptostreptococcus species, Bacteroides fragilis, Bacteroides distasonis, Bacteroides ovatus, Bacteroides thetaiotaomicron, or Bacteroides uniformis, (2) complicated skin and skin structure infections, including diabetic foot infections without osteomyelitis due to Staphylococcus aureus (methicillin susceptible isolates only), Streptococcus agalactiae, Streptococcus pyogenes, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Bacteroides fragilis, Peptostreptococcus species, Porphyromonas asaccharolytica, or Prevotella bivia, (3) community acquired pneumonia due to Streptococcus pneumoniae (penicillin susceptible isolates only) including cases with concurrent bacteremia, Haemophilus influenzae (beta-lactamase negative isolates only), or Moraxella catarrhalis, (4) complicated urinary tract infections including pyelonephritis due to Escherichia coli, including cases with concurrent bacteremia, or Klebsiella pneumoniae, (5) acute pelvic infections including postpartum endomyometritis, septic abortion and post surgical gynecologic infections due to Streptococcus agalactiae, Escherichia coli, Bacteroides fragilis, Porphyromonas asaccharolytica, Peptostreptococcus species, or Prevotella bivia.

Ertapenem Pharmacology

Ertapenem has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria.

Ertapenem Absorption

The mean bioavailability is approximately 90%.

Ertapenem side effects and Toxicity

No information avaliable

Ertapenem Patient Information

Ertapenem Organisms Affected

Enteric bacteria and other eubacteria